TCL Archive Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million. July 30, 2004
TCL Archive In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says February 12, 1999
TCL Archive CT Scanning Advocates Propose Pooling Data From Randomized Trials, I-ELCAP. November 16, 2007
TCL Archive FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined. August 7, 2009
